Quick Takeaways
- This page summarizes Pascal Touchon's Form 4 filing for Atara Biotherapeutics, Inc. (ATRA).
- 3 reported transactions and 1 derivative row are listed below.
- Filing timestamp: 03 Mar 2022, 18:02.
Pascal Touchon - 01 Mar 2022 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)
- Signature
- /s/ David Tucker, Attorney-in-Fact for Pascal Touchon
- Issuer symbol
- ATRA
- Transactions as of
- 01 Mar 2022
- Net transactions value
- -$87,009
- Form type
- 4
- Filing time
- 03 Mar 2022, 18:02:34 UTC
- Previous filing
- 18 Nov 2021
- Next filing
- 19 May 2022
- SEC
- View on sec.gov
Quoteable Key Fact
"Pascal Touchon filed Form 4 for Atara Biotherapeutics, Inc. (ATRA) on 03 Mar 2022."
What Changed
- Previous filing in this sequence was filed on 18 Nov 2021.
- Current net transaction value: -$87,009.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ATRA | Common Stock | Award | $0 | +180,565 | +55% | $0.000000 | 509,054 | 01 Mar 2022 | Direct | F1 |
| transaction | ATRA | Common Stock | Sale | $87,009 | -8,828 | -1.7% | $9.86 | 500,226 | 01 Mar 2022 | Direct | F2, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ATRA | Employee Stock Option (Right to Buy) | Award | $0 | +339,419 | $0.000000 | 339,419 | 01 Mar 2022 | Common Stock | 339,419 | $10.21 | Direct | F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | These restricted stock units vest in 16 equal quarterly installments on each Company Quarterly Vesting Date (as defined below), with the initial installment vesting on May 15, 2022, subject to the reporting person's continuous service. Company Quarterly Vesting Date means March 1, May 15, August 15 and November 15 of each year. |
| F2 | Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted restricted stock units. |
| F3 | The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 1, 2022 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee. |
| F4 | 1/48th of the shares subject to the stock option vest and become exercisable each month with the initial installment vesting on April 1, 2022, subject to the reporting person's continuous service. |